Cell Therapy

Cell Therapy

Why are we using stem cells in therapy?

Stem cell therapy is considered a major medical breakthrough. It is a treatment that uses stem cells to replace or heal damaged tissues. The stem cells can be put into the blood, or transplanted into the damaged tissue directly. This therapy potentially holds the promise of treatment for many hitherto incurable malignancies, genetic diseases, neurological diseases and other life-threatening diseases.

These include:

  • Amyotrophic Lateral Sclerosis (ALS)
  • Alzheimer’s
  • Spinal cord injury
  • Multiple Sclerosis
  • Parkinson’s disease
  • Hematologic/oncologic disorders
  • Cardiovascular diseases
  • Diabetes
  • Rheumatoid arthritis
  • Cerebral palsy
  • Infertility
  • Obstructive pulmonary disease and skin conditions

These cells offer exciting viable treatment options for a huge number of patients. The last decade has witnessed remarkable progress in the understanding of stem cell biology, including pioneering insights into the therapeutic potential of stem cells.

Applications at Reviva

At Reviva’s center, patients suffering from life-threatening diseases are enrolled into the cell therapy program following a careful application process.

This is carried out through the evaluation of the patient’s medical file by the cell therapy committee.

The clinical assessment is performed according to specific guidelines, and the protocol adopted is assessed continuously.

Evaluation is performed according to a strict schedule and under the supervision of professional personnel in different fields of expertise.

Autologous stem cell transplantation is carried out to inject specific stem cells collected from several sources, such as bone marrow, fat, peripheral blood, etc.

These adult stem cells have the potential to differentiate into different type of cells and perform a crucial role in tissue repair.

Reviva quality control


Reviva offers you an accurate method of stem cells purification with specific marker selection, depleting cells – including lymphocyte T and B cells – that can lead to complications such as GVHD. It is not a case of transplanting just any cells to patients’ tissues; rather, a carefully selected sample of cells is selected using specific markers, to then be directed against particular diseases.
In addition, the highly sophisticated platform allows for the possibility of specific cell orientation via advanced techniques to target specific type of tissues and damaged organs.
Mononuclear cells are separated from the blood sample using a closed automated system under sterile conditions; selective stem cells such as Mesenchymal stem cells or Hematopoietic stem cells can then be used in treatment.